RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts. - Watts GF; Schwabe C; Scott R; Gladding PA; Sullivan D; Baker J; Clifton P; Hamilton J; Given B; Melquist S; Zhou R; Chang T; et al. (Nature medicine, 2023)